iPierian receives $1.5M Basic Biology Award from CIRM to study cellular reprogramming

iPierian, Inc., the leading company focused on creating new therapeutics discovered using cellular reprogramming and directed differentiation of patient cells, today announced that it has been awarded a three-year $1.5 million "Basic Biology Award" from the California Institute of Regenerative Medicine (CIRM). The grant will be used to fund the study of mechanisms of cellular reprogramming with the specific aim of enhancing the efficiency of reprogramming techniques.

"Patient-derived induced pluripotent stem cells (iPS cells) offer immediate utility for discovering new therapeutics to treat serious diseases, as well as future potential for cellular therapy. This research program is designed to provide valuable insights into the biological pathways and molecular targets involved in inducing pluripotent stem cells," said John P. Walker, chief executive officer of iPierian.

Through the grant, entitled "Cellular Reprogramming: Dissecting the Molecular Mechanism and Enhancing Efficiency," iPierian will identify and study small molecules that promote the reprogramming of human somatic cells to pluripotent cells. First, a large number of compounds will be screened using an established assay to detect early markers for the induction of pluripotency. Next, the mechanisms of action of confirmed lead compounds will be studied using a variety of genomic profiling, bioinformatics and RNAi based approaches. Candidate small molecules will then be used to generate iPS cell lines. A more detailed summary of the grant application can be found on the CIRM website at http://www.cirm.ca.gov/ReviewReports_RB2-01628.

Mr. Walker continued, "iPierian greatly appreciates and recognizes the significance of the support of stem cell research by the voters of the State of California. CIRM funding of this program will enable us to advance the science and our understanding of cellular reprogramming.  CIRM's overall research funding enhances California's leadership in applying stem cell research to the discovery of new therapeutics and the potential of finding new treatment regimens for many diseases for which no effective treatments yet exist."

Source:

iPierian, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Active commuters less likely to suffer from heart disease and cancer, new research shows